Total Payments
$94,413
2024 Payments
$667.57
Companies
10
Transactions
131
Medicare Patients
9,718
Medicare Billing
$599,546
Payment Breakdown by Category
Other$81,750 (86.6%)
Travel$8,480 (9.0%)
Food & Beverage$4,074 (4.3%)
Research$108.19 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $81,750 | 27 | 86.6% |
| Travel and Lodging | $8,480 | 23 | 9.0% |
| Food and Beverage | $4,074 | 80 | 4.3% |
| Unspecified | $108.19 | 1 | 0.1% |
Payments by Type
General
$94,305
130 transactions
Research
$108.19
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $92,598 | 86 | $0 (2024) |
| Abbott Laboratories | $790.57 | 19 | $0 (2023) |
| ABIOMED | $339.84 | 4 | $0 (2024) |
| CVRx, Inc. | $242.40 | 4 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $140.27 | 2 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $107.49 | 7 | $0 (2024) |
| Medtronic, Inc. | $74.73 | 4 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $74.46 | 3 | $0 (2024) |
| ATRICURE, INC. | $25.84 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $19.34 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $667.57 | 18 | ABIOMED ($248.61) |
| 2023 | $198.20 | 6 | Abbott Laboratories ($182.71) |
| 2022 | $358.85 | 7 | Abbott Laboratories ($206.18) |
| 2021 | $262.46 | 4 | Abbott Laboratories ($166.30) |
| 2020 | $36.96 | 2 | Abbott Laboratories ($36.96) |
| 2019 | $203.32 | 6 | Abbott Laboratories ($145.81) |
| 2018 | $43.14 | 3 | Novartis Pharmaceuticals Corporation ($24.52) |
| 2017 | $92,643 | 85 | Novartis Pharmaceuticals Corporation ($92,442) |
All Payment Transactions
131 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/05/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $19.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Not Applicable | ||||||
| 07/26/2024 | Medtronic, Inc. | FFRANGIO (Device) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Fractional Flow Reserve (FFR) Systems | ||||||
| 07/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/23/2024 | Medtronic, Inc. | FFRANGIO (Device) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Fractional Flow Reserve (FFR) Systems | ||||||
| 07/16/2024 | Medtronic, Inc. | FFRANGIO (Device) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Fractional Flow Reserve (FFR) Systems | ||||||
| 07/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $2.38 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/11/2024 | Medtronic, Inc. | FFRANGIO (Device) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Fractional Flow Reserve (FFR) Systems | ||||||
| 07/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $32.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/06/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/22/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Not Applicable | ||||||
| 05/16/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $129.66 | General |
| Category: Heart Failure and Hypertension | ||||||
| 04/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.34 | General |
| Category: Cardiovascular | ||||||
| 04/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/04/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $121.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/02/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: Not Applicable | ||||||
| 01/29/2024 | ABIOMED | Impella (Device) | — | In-kind items and services | $108.19 | Research |
| Study: Protect IV • Category: Cardiology/Vascular Diseases | ||||||
| 12/14/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.31 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/12/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $8.90 | General |
| Category: Heart Failure | ||||||
| 07/06/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Heart Failure | ||||||
| 04/13/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $144.38 | General |
| Category: Heart Failure | ||||||
| 03/03/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Heart Failure | ||||||
| 02/09/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $4.18 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/22/2022 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $12.40 | General |
| Category: Heart Failure and Hypertension | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Protect IV | ABIOMED | $108.19 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,466 | 2,813 | $386,707 | $116,973 |
| 2022 | 21 | 2,987 | 3,706 | $431,262 | $164,867 |
| 2021 | 17 | 2,128 | 2,673 | $468,934 | $151,899 |
| 2020 | 21 | 2,137 | 2,866 | $478,098 | $165,806 |
Total Patients
9,718
Total Services
12,058
Medicare Billing
$599,546
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 128 | 131 | $55,779 | $17,638 | 31.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 106 | 167 | $41,625 | $15,337 | 36.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 204 | 204 | $56,805 | $14,553 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 164 | 187 | $42,155 | $14,310 | 33.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 142 | 224 | $32,768 | $13,720 | 41.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 184 | 184 | $36,972 | $9,631 | 26.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 23 | 43 | $24,336 | $6,888 | 28.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 38 | $13,288 | $4,685 | 35.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 544 | 648 | $21,225 | $3,393 | 16.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $9,292 | $2,888 | 31.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 249 | 252 | $15,939 | $2,415 | 15.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 15 | $5,804 | $2,375 | 40.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 36 | 36 | $5,400 | $1,959 | 36.3% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 19 | 19 | $4,673 | $1,571 | 33.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 275 | 286 | $4,862 | $1,456 | 29.9% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 21 | 48 | $2,448 | $799.30 | 32.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 38 | 38 | $1,634 | $611.24 | 37.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 47 | 54 | $2,322 | $598.10 | 25.8% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 29 | 29 | $1,526 | $585.85 | 38.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 24 | 24 | $2,016 | $419.52 | 20.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 37 | 37 | $1,036 | $392.76 | 37.9% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 20 | 20 | $820.00 | $275.92 | 33.6% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 17 | 17 | $2,652 | $148.58 | 5.6% |
| 85610 | Blood test, clotting time | Office | 2023 | 25 | 30 | $494.00 | $126.00 | 25.5% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 23 | 23 | $490.00 | $114.87 | 23.4% |
About Dr. Stephen Rennyson, MD
Dr. Stephen Rennyson, MD is a Cardiovascular Disease healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912035767.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Rennyson, MD has received a total of $94,413 in payments from pharmaceutical and medical device companies, with $667.57 received in 2024. These payments were reported across 131 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($81,750).
As a Medicare-enrolled provider, Rennyson has provided services to 9,718 Medicare beneficiaries, totaling 12,058 services with total Medicare billing of $599,546. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Charlotte, NC
- Active Since 03/02/2007
- Last Updated 07/16/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1912035767
Products in Payments
- ENTRESTO (Drug) $92,524
- Impella (Device) $339.84
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $279.38
- Barostim Neo System (Device) $242.40
- MitraClip System (Device) $143.56
- Optimizer (Device) $140.27
- LifeVest (Device) $107.49
- CardioMEMS HF System (Device) $97.44
- HeartMate (Device) $81.22
- MITRACLIP (Device) $79.99
- FFRANGIO (Device) $74.73
- Arcalyst (Drug) $74.46
- LEQVIO (Drug) $73.68
- HeartMate 3 Left Ventricular Dev (Device) $54.37
- CARDIOMEMS (Device) $29.52
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $25.84
- Circulatory Support (Device) $25.09
- CAMZYOS (Drug) $19.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Charlotte
Frank Arko, Md, MD
Cardiovascular Disease — Payments: $3.1M
Cardiovascular Disease $3.1M
Dr. Oluseun Alli, Md, MD
Cardiovascular Disease — Payments: $454,288
Cardiovascular Disease $454,288
Jonathan Schwartz, Md, MD
Cardiovascular Disease — Payments: $160,159
Cardiovascular Disease $160,159
John Pasquini, Md, MD
Cardiovascular Disease — Payments: $57,261
Cardiovascular Disease $57,261
Edward Mcmillan, Md, MD
Cardiovascular Disease — Payments: $41,685
Cardiovascular Disease $41,685
Sherry Saxonhouse, Md, MD
Cardiovascular Disease — Payments: $39,944
Cardiovascular Disease $39,944